 |
| SHRI N.G.KULKARNI |
New Delhi, 28 Apr: A gang of five persons, including two pharmacists, were arrested by the Delhi Police for allegedly siphoning off medicines meant for the poor from the government-run Hedgewar Hospital, police said on Thursday. Medicines worth Rs 60 lakh were recovered from the accused, identified as Ashwani Sharma (35), Pyare Ali (35), Hakim Singh (45), Dharmender Kumar (40) and Narender Sharma (56). Narender is the head pharmacist at Hedgewar Hospital, while Kumar works under him, Sanjay Kumar Jain, DCP (Northeast) said. "Ashwani and Narender were the kingpins, were operating the gang for a year," Jain added. |
NEW DELHI, 28 APR: Three out of every five deaths in 2008 were caused by non-communicable diseases (NCDs) like cancer, stroke, diabetes and cardiovascular diseases. What's worse, deaths caused by these diseases are expected to increase by 15% in the next decade - from 36 million in 2008 to 44 million in 2020. In 2030, it will cross the 50 million mark. The region projected to have the greatest total number of NCD deaths in 2020 is South-East Asia - 10.4 million deaths. These stats are bound to bother India since 80% of these deaths occurred and will occur in low and middle income countries, according to the first global status report on NCDs launched on Wednesday by the World Health Organization. |
New Delhi, 27 Apr: The oral single drug formulation of Artemisinin, having potential to become resistant to malaria, has been withdrawn from India. However, some manufacturers continue to produce and export it as a mono therapy. On Tuesday, the Drug Controller General of India (DCGI) asked the state drug controllers to cancel the licence of such manufacturers with immediate effect. |
Kuala Lumpur, 26 Apr: Two Indian nationals have been sentenced to death by two separate Malaysian High Courts for trafficking in 12 kg of ketamine drug, reports said on Tuesday. In the first case, the High Court here sentenced Samad Mohamad Sulthan, to death for trafficking in 3.9 kg of ketamine at the Kuala Lumpur International Airport (KLIA) two years ago, national news agency Bernama said. |
| P A Francis Tuesday, April 19, 2011, 08:00 Hrs [IST] |
Early this month, Supreme Court passed a significant judgement on a case involving GSK and the Central government on overcharging of certain drugs in violation of Drug Price Control Order of 1979. The company was asked by the apex court to pay a sum of Rs.71.21 crore to the government marking the end of a 20-year old dispute over the pricing of Betamethasone Alcohol, Betamethasone 17 valerate and Betamethasone di Sodium Phosphate. These drugs were used for manufacturing formulations for skin-related problems and fungal infection. By delivering the judgement, the Supreme court set aside a Delhi High Court order which in 1991 rejected the government’s demand on GSK as illegal and arbitrary. |
Mumbai, 20 Apr: The union health ministry has finalised the 9-member expert committee to go into the issue of efficacy and safety data of human placental extract which has been banned by the government along with some other controversial drugs including the non-steroid anti-inflammatory drug nimesulide suspension, gastroprokinetic agent cisapride and decongestant drug Phenylpropanolamine (PPA) on February 10 this year. Renowned pharmacologist Dr YK Gupta of AIIMS will head the panel. Other members of the committee include Dr Ajay Kumar of IMA, Dr Vijay Kumar of IDRI, Dr Sharma of ICMR, Dr Kotwal of AIIMS, Dr VK Tiwari, Dr VK Chakravorthy, Dr CM Sharma and Dr Lakhbir Dhaliwal of PGI, Chandigarh. |
NEW DELHI, 16 APR: India is banning both availability and over-the-counter sale of latest generation of antibiotics from general pharmacies in a bid to put a stop to the country's obsession with popping a pill. The move will make 'wonder drugs' ineffective. A notification will be issued on Monday by drug controller general of India (DCGI) Dr Surinder Singh that will put around 90 antibiotics under a new schedule, HX, as per the Drugs and Cosmetics Act. |
Mumbai, 8 Apr: The Delhi High Court has refused to grant stay on the union health ministry's recent notification banning the controversial medicine human placental extract which was banned by the ministry along with some other controversial drugs including the non-steroid anti-inflammatory drug nimesulide suspension, gastroprokinetic agent cisapride and decongestant drug Phenylpropanolamine (PPA) on February 10 this year. Refusing to grant stay order, the court has constituted a 9-member expert committee to go into the issue of efficacy and safety data of human placental extract and the expert committee has been asked to submit a report within one month time. |
Sl.no | Name of the Product | B.No. | D/M E/M | Mfd.by |
01 | Aceclofenac & paracetamol Dispersible tab.(ANMOL) | DOT1 2/539 | 12/09 11/11 | M/S R.H.Laboratories, Opp Gondpur Industrial Area.Paonta Sahib(H.P) |
